Fairvalue-Calculator Fairvalue-Calculator
EN DE

Implanet S.A (IMPZY) Fair Value & Analysis

Healthcare · US · Market cap $230M

Price$0.0800
Fair Value$0.0200
Upside-75.0%
Quality95/100
Evidence: Low Range $0.0100 – $0.0200

Fair value as of: Jun 23, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Implanet S.A (IMPZY) currently trades at $0.0800, while our model-based Fair Value estimate is $0.0200 — implying the stock looks roughly 75.0% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Olea, Saxxo, Swingo, Shark, Origin, and Jazz Frame, as well as ISS-Jazz Screw systems for posterior fixation. It also provides an ultrasonic osteotomy surgical system; and knee prostheses under the Madison name. The company exports its products. Implanet S.A. was founded in 2006 and is headquartered in Martillac, France.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -9% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -5% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is Implanet S.A (IMPZY) undervalued?
As of Jun 23, 2026, our model estimates a fair value of $0.0200 versus a price of $0.0800 — about −75% (overvalued). Model-based estimate, not financial advice.
What is the fair value of IMPZY?
Our 21-model fair value for Implanet S.A is $0.0200 (as of Jun 23, 2026), built from audited fundamentals. The current price is $0.0800.
What is the quality score of IMPZY?
Implanet S.A has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.